{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:42:39Z","timestamp":1790736159069,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002905","name":"Ministerio de Salud y Protecci\u00f3n Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111568","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T11:39:00Z","timestamp":1564400340000},"page":"111568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani"],"prefix":"10.1016","volume":"182","author":[{"given":"Sobinson","family":"Ars\u00e8ne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"G\u00f3mez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Escarcena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Abeng\u00f3zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8355-8373","authenticated-orcid":false,"given":"Montserrat","family":"N\u00e1cher-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"San Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gamarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther del","family":"Olmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111568_bib1","series-title":"RSC Drug Discovery Series","first-page":"3","article-title":"Appraisal of leishmaniasis chemotherapy, current status and pipeline strategies. Chapter 1: leishmaniasis, impact and therapeutic needs","author":"Alvar","year":"2018"},{"key":"10.1016\/j.ejmech.2019.111568_bib2","author":"WHO Fact-Sheets: Leishmaniasis"},{"key":"10.1016\/j.ejmech.2019.111568_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111568_bib4","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"A\u00a0review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo TP","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.111568_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00048-18","article-title":"Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.111568_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/1386207319666160506123921","article-title":"Natural products as a source for antileishmanial and antitrypanosomal agents","volume":"19","author":"Scotti","year":"2016","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.ejmech.2019.111568_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0030-1250663","article-title":"Current approaches to discover marine antileishmanial natural products","volume":"77","author":"Tempone","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2019.111568_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/138955751503150312120912","article-title":"Topoisomerase 1B as a target against leishmaniasis","volume":"15","author":"D'Annessa","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpddr.2014.07.006","article-title":"Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery","volume":"4","author":"Bala\u00f1a-Fouce","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2019.111568_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4155\/fmc-2016-0180","article-title":"Polyamine-trypanothione pathway: an update","volume":"9","author":"Ilari","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib11","first-page":"873230","article-title":"Role of heme and heme-proteins in trypanosomatid essential metabolic pathways","author":"Tripodi","year":"2011","journal-title":"Enzym. Res."},{"key":"10.1016\/j.ejmech.2019.111568_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2018.02.010","article-title":"Recent progress in drug targets and inhibitors towards combating leishmaniasis","volume":"181","author":"Vijayakumar","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2019.111568_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/iub.1759","article-title":"Recent advances in understanding Leishmania donovani infection: the importance of diverse host regulatory pathways","volume":"70","author":"Saha","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejmech.2019.111568_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2014.04.003","article-title":"Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects","volume":"30","author":"Patterson","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2019.111568_bib15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.jmedchem.8b01218","article-title":"Identification of GSK3186899\/DDD853651 as a preclinical development candidate for the treatment of visceral Leishmaniasis","volume":"62","author":"Thomas","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib16","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0960-894X(03)00509-2","article-title":"The imidazo[2,1-a]isoindole system. A new skeletal basis for antiplasmodial compounds","volume":"13","author":"del Olmo","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111568_bib17","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1021\/jo00105a010","volume":"59","author":"Noda","year":"1994","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sleep.2017.02.020","article-title":"Mazindol: a risk factor for pulmonary arterial hypertension?","volume":"34","author":"Konofal","year":"2017","journal-title":"Sleep Med."},{"key":"10.1016\/j.ejmech.2019.111568_bib19","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1016\/j.ejmech.2011.08.043","article-title":"Antimalarial activity of imidazo[2,1-a]isoindol-5-ol derivatives and related compounds","volume":"46","author":"del Olmo","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib20","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/S0960-894X(01)00562-5","article-title":"Anti-Trypanosoma activity of some natural stilbenoids and synthetic related heterocyclic compounds","volume":"11","author":"del Olmo","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111568_bib21","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.bmcl.2006.04.087","article-title":"Anti-HIV activity of stilbene-related heterocyclic compounds","volume":"16","author":"Bedoya","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111568_bib22","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0960-894X(01)00387-0","article-title":"Leishmanicidal activity of some stilbenoids and related heterocyclic compounds","volume":"11","author":"del Olmo","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111568_bib23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1017\/S0031182010000077","article-title":"Central carbon metabolism of Leishmania parasites","volume":"137","author":"Saunders","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2019.111568_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003888","article-title":"Induction of a stringent metabolic response in intracellular stages of Leishmania mexicana leads to increased dependence on mitochondrial metabolism","volume":"10","author":"Saunders","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.111568_bib25","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/jm901677h","article-title":"New Benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex II","volume":"53","author":"Rom\u00e1n Luque-Ortega","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/bj20030544","article-title":"Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular. ATP","volume":"375","author":"Luque-Ortega","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2019.111568_bib27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1091\/mbc.E17-04-0217","article-title":"Phospholipid flippases and Sfk1p, a novel regulator of phospholipid asymmetry, contribute to low permeability of the plasma membrane","volume":"29","author":"Mioka","year":"2018","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2019.111568_bib28","first-page":"e614014","article-title":"The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics","author":"Menna-Barreto","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2019.111568_bib29","series-title":"Mitochondrial Dysfunction: Risk Factors, Symptoms and Treatment Options","first-page":"75","article-title":"Mitochondrial dysfunction of a coworker in treatment of Trypanosoma cruzi and Leishmania amazonensis infection","author":"Nakamura","year":"2014"},{"key":"10.1016\/j.ejmech.2019.111568_bib30","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1007\/s11095-011-0586-3","article-title":"Mitochondria and trypanosomatids: targets and drugs","volume":"28","author":"Fidalgo","year":"2011","journal-title":"Pharma Res."},{"key":"10.1016\/j.ejmech.2019.111568_bib31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111568_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molbiopara.2008.12.007","article-title":"Paromomycin: uptake and resistance in Leishmania donovani","volume":"164","author":"Jhingran","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2019.111568_bib33","first-page":"1","article-title":"Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure","volume":"74","author":"Rodrigues","year":"2014","journal-title":"Sub Cell. Biochem."},{"key":"10.1016\/j.ejmech.2019.111568_bib34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/AAC.01545-10","article-title":"Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major","volume":"55","author":"Manzano","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111568_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004684","article-title":"Leishmania infantum modulates host macrophage mitochondrial metabolism by hijacking the SIRT1-AMPK Axis","volume":"11","author":"Moreira","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2019.111568_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2019.111568_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A\u00a0knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J.\u00a0Comb. Chem."},{"key":"10.1016\/j.ejmech.2019.111568_bib40","series-title":"Combinatorial Library Design and Evaluation- Principles, Software, Tools and Applications in Drug Discovery","first-page":"301","article-title":"Tools for designing diverse, drug-like, cost-effective combinatorial libraries","author":"Brown","year":"2001"},{"key":"10.1016\/j.ejmech.2019.111568_bib41","series-title":"RSC Drug Discovery Series","first-page":"24","article-title":"Anti-leishmanial drug discovery: past, present and future perspectives","author":"Mowbray","year":"2018"},{"key":"10.1016\/j.ejmech.2019.111568_bib42","series-title":"Purification of Laboratory Chemicals","author":"Armarego","year":"2000"},{"key":"10.1016\/j.ejmech.2019.111568_bib43","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.02481-13","article-title":"4-Amino bis-pyridinium derivatives as novel antileishmanial agents","volume":"58","author":"G\u00f3mez-P\u00e9rez","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.111568_bib44","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1039\/C5RA02627J","article-title":"Antileishmanial activity of sp2-iminosugar derivatives","volume":"5","author":"Sanchez-Fern\u00e1ndez","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.111568_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003704","article-title":"Fitness of Leishmania donovani parasites resistant to drug combinations","volume":"9","author":"Garc\u00eda-Hern\u00e1ndez","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2019.111568_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-1-60761-594-1_25","article-title":"Characterization of the leishmanicidal activity of antimicrobial peptides","volume":"618","author":"Luque-Ortega","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111568_bib47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/AAC.45.4.1121-1125.2001","article-title":"In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism","volume":"45","author":"Luque-Ortega","year":"2001","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419306981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419306981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:56:51Z","timestamp":1759327011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419306981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":45,"alternative-id":["S0223523419306981"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111568","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111568"}}